EFFECT OF LIVER-DISEASE ON DEXTROMETHORPHAN OXIDATION CAPACITY AND PHENOTYPE - A STUDY IN 107 PATIENTS

被引：25

作者：

LARREY, D ^{[1
]}

BABANY, G ^{[1
]}

TINEL, M ^{[1
]}

FRENEAUX, E ^{[1
]}

AMOUYAL, G ^{[1
]}

HABERSETZER, F ^{[1
]}

LETTERON, P ^{[1
]}

PESSAYRE, D ^{[1
]}

机构：

[1] HOP BEAUJON,SERV HEPATOL,F-92118 CLICHY,FRANCE

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1989年 / 28卷 / 03期

关键词：

D O I：

10.1111/j.1365-2125.1989.tb05430.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：297 / 304

页数：8

共 19 条

[1]

DISTLERATH LM, 1985, J BIOL CHEM, V260, P9057

[2] CHARACTERIZATION OF THE COMMON GENETIC-DEFECT IN HUMANS DEFICIENT IN DEBRISOQUINE METABOLISM [J].

GONZALEZ, FJ ;

SKODA, RC ;

KIMURA, S ;

UMENO, M ;

ZANGER, UM ;

NEBERT, DW ;

GELBOIN, HV ;

HARDWICK, JP ;

MEYER, UA .

NATURE, 1988, 331 (6155) :442-446

[3]

GU J, 1986, J BIOL CHEM, V261, P11734

[4] DEBRISOQUINE-TYPE POLYMORPHISM OF DRUG OXIDATION - PURIFICATION FROM HUMAN-LIVER OF A CYTOCHROME-P450 ISOZYME WITH HIGH-ACTIVITY FOR BUFURALOL HYDROXYLATION [J].

GUT, J ;

GASSER, R ;

DAYER, P ;

KRONBACH, T ;

CATIN, T ;

MEYER, UA .

FEBS LETTERS, 1984, 173 (02) :287-290

[5] GENETICALLY-DETERMINED POLYMORPHISMS IN DRUG OXIDATION [J].

JACQZ, E ;

HALL, SD ;

BRANCH, RA .

HEPATOLOGY, 1986, 6 (05) :1020-1032

[6]

Jaffe J. H, 1985, PHARMACOL BASIS THER, P491

[7] ASSAY AND CHARACTERIZATION OF DEBRISOQUINE 4-HYDROXYLASE ACTIVITY OF MICROSOMAL FRACTIONS OF HUMAN-LIVER [J].

KAHN, GC ;

BOOBIS, AR ;

MURRAY, S ;

BRODIE, MJ ;

DAVIES, DS .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (05) :637-645

[8]

KUPFER A, 1983, SEMIN LIVER DIS, V3, P341, DOI 10.1055/s-2008-1040786

[9]

KUPFER A, 1984, LANCET, V2, P584

[10] OXIDATION PHENOTYPING IN ALCOHOLICS WITH LIVER-DISEASE OF VARYING SEVERITY [J].

LANTHIER, PL ;

RESHEF, R ;

SHAH, RR ;

OATES, NS ;

SMITH, RL ;

MORGAN, MY .

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1984, 8 (05) :435-441

← 1 2 →